RECALL RECORD — CLASS IIRecall closedD-0242-2022/FDA enforcement
Tinactin·Cosmetics·Oct 1, 2021

(Tolnaftate 1%) Deodorant Powder Spray NET WT 133g (4.6 OZ) Can, Labeled as (a)

What you need to know

Class II
  • What happened

    CGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

  • Action required

    Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement.

Recall closed · classified by the FDANationwide (US)More cosmetics

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA COSMETICS

Brand nameTinactin
Recalling firmBayer Healthcare Pharmaceuticals INC.Whippany, NJ, United States
UPC / barcodes
3 11017 41000 4
Lot / date codes
  • Lot # (a) TN004BW, EXP 7/31/2022, (b) TN00678, EXP 8/31/2022
  • TN00679, EXP 9/30/2022
Distribution area
Nationwide

Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

United States, Canada, Mexico, Puerto Rico

Quantity affected738, 432 cans
Recall initiationFDA report date: November 24, 2021
FDA recall numberD-0242-2022

Beyond the headline

The recall, in context

Bayer Healthcare Pharmaceuticals INC. initiated this cosmetics recall on October 1, 2021. The FDA enforcement report states: CGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. The FDA report lists distribution as: Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

The FDA enforcement report describes the reason as: CGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

(Tolnaftate 1%) Deodorant Powder Spray NET WT 133g (4.6 OZ) Can, Labeled as (a) was made or distributed by Bayer Healthcare Pharmaceuticals INC. in Whippany, NJ, United States. This page reflects FDA report D-0242-2022, dated November 24, 2021.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Set the product aside and do not apply it.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Benzene contamination

Possible health effects

Benzene is a known human carcinogen. Long-term exposure is associated with blood disorders and cancer. A recall is a precautionary step to reduce exposure.

When symptoms may appear

Health effects are generally associated with repeated or long-term exposure rather than a single incubation period.

Higher-risk groups

People who use the affected product frequently, pregnant people, children and people with existing blood disorders should be especially cautious.

What to do now

  1. 1Stop using the affected cosmetic or personal-care product immediately.
  2. 2Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute.
  3. 3If you have concerns about exposure or symptoms, speak with a healthcare professional.

Benzene is a known human carcinogen; this information is not a personal exposure assessment.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the (Tolnaftate 1%) Deodorant Powder Spray NET WT 133g (4.6 OZ) Can, Labeled as (a) recall?

Tinactin recalled (Tolnaftate 1%) Deodorant Powder Spray NET WT 133g (4.6 OZ) Can, Labeled as (a) in an FDA Class II enforcement action reported as D-0242-2022. CGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

What should I do if I bought this product?

Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement. Stop using the affected cosmetic or personal-care product immediately. Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute. If you have concerns about exposure or symptoms, speak with a healthcare professional.

Is the Tinactin recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record D-0242-2022. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Tinactin

View brand

Related alerts

Recent Benzene recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.